Sign In
Buy COSM
$0.247
-0.0143 (-5.48%)
At Close: Jun 03, 2026
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
09:25am, Monday, 26'th Jul 2021
CEO has converted $4.0 million of the Company's debt to date; the conversion price represents a premium to market CEO has converted $4.0 million of the Company's debt to date; the conversion price rep
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share
09:38am, Friday, 16'th Jul 2021
The conversion price represents a premium to market The conversion price represents a premium to market
First Phase Launches Sky Premium Life Products on Amazon and eBay; Second Phase Launch Includes Brick & Mortar Stores
Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board
09:15am, Thursday, 01'st Jul 2021
CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of branded and generic pharmaceutical
Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share
09:25am, Monday, 28'th Jun 2021
The conversion price represents a premium to market The conversion price represents a premium to market
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon UK
09:15am, Tuesday, 27'th Apr 2021
Marks First Step in Global E-Commerce Strategy; Reaffirms Plans to Enter New European and Global Markets in 2021 Marks First Step in Global E-Commerce Strategy; Reaffirms Plans to Enter New European a
Cosmos Holdings Reports Revenue Growth of 40% to a Record $55.4 Million and Achieves Profitability for 2020
09:15am, Friday, 16'th Apr 2021
CHICAGO, April 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), a vertically integrated, international pharmaceutical company with a proprietary line of branded and
Cosmos Holdings Launches Proprietary King Eros and Queen Venus Supplements for Enhanced Libido
09:16am, Wednesday, 14'th Apr 2021
King Eros supplement formula developed to improve sexual health and men's libido
Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
10:05am, Thursday, 08'th Apr 2021
New proprietary formula for the symptomatic relief of pain and irritated sore throat
Cosmos Holdings Launches Osteodome in EU
09:35pm, Thursday, 11'th Feb 2021
New Proprietary Dietary Supplement Contributes to Normal Bone and Cartilage Health and Joint Flexibility
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement
09:30am, Monday, 11'th Jan 2021
CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and ge
Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market
12:23pm, Friday, 04'th Dec 2020
Company Began Trading as OTCQX: COSM on November 25, 2020 Company Began Trading as OTCQX: COSM on November 25, 2020
Cosmos Holdings Begins Trading on the OTCQX® Best Market
09:46am, Wednesday, 25'th Nov 2020
CHICAGO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and ge
